This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción DNA
Doric Nimrod Air One Limited was formerly known as Future Leasing Yield Company Limited.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Competidores de Doric Nimrod Air One Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.60 |
| 52 Week High | UK£0.65 |
| 52 Week Low | UK£0.27 |
| Beta | 0 |
| 1 Month Change | -3.23% |
| 3 Month Change | 0.84% |
| 1 Year Change | 93.55% |
| 3 Year Change | -6.98% |
| 5 Year Change | -41.18% |
| Change since IPO | -42.03% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| DNA | GB Trade Distributors | Mercado GB | |
|---|---|---|---|
| 7D | 0% | -2.4% | 1.0% |
| 1Y | 93.5% | 13.6% | 3.0% |
Rentabilidad vs. Industria: DNA exceeded the UK Trade Distributors industry which returned 3.5% over the past year.
Rentabilidad vs. Mercado: DNA exceeded the UK Market which returned -3.1% over the past year.
Volatilidad de los precios
| DNA volatility | |
|---|---|
| DNA Average Weekly Movement | 1.6% |
| Trade Distributors Industry Average Movement | 3.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.7% |
Precio estable de las acciones: DNA has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: DNA's weekly volatility has decreased from 11% to 2% over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| n/a | n/a | n/a | n/a |
Resumen de fundamentos de Doric Nimrod Air One Limited
| Estadísticas fundamentales de DNA | |
|---|---|
| Capitalización bursátil | UK£25.47m |
| Beneficios(TTM) | UK£0 |
| Ingresos (TTM) | n/a |
n/a
Ratio precio-beneficio (PE)n/a
Ratio precio-ventas (PS)¿Está DNA sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de DNA | |
|---|---|
| Ingresos | UK£0 |
| Coste de los ingresos | UK£0 |
| Beneficio bruto | UK£0 |
| Otros gastos | UK£0 |
| Beneficios | UK£0 |
Últimos beneficios comunicados
n/a
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0.0% |
¿Cómo se ha desempeñado DNA a largo plazo?
Ver rendimiento histórico y comparativa